ClinForecast: AI-powered forecasting for clinical trials to enhance clinical development efficiency
Description
ClinForecast, an AI/ML-powered solution designed to revolutionize and optimize our understanding of clinical development by providing data-driven foresight. The system's core capability is to accurately estimate key trial parameters, such as the overall phase duration (e.g., Phase 1, 2, or 3), and suggest optimal variables, including patient enrollment numbers and the number of sites needed. By mapping variables like Mechanism of Action (MoA), clinical endpoints, and disease stage, ClinForecast provides strategic insights that allow refinement of study protocols, mitigate risks and ultimately accelerate the efficient delivery of new therapies to patients. By leveraging systematic comparative analysis of clinical trial data, this platform also offers a strategic advantage to pharmaceutical companies and investors seeking to participate in high-impact trials in different stages of clinical development.
